波立维联合通心络胶囊治疗非ST段抬高型急性心肌梗死的疗效及对CK、CK-MB、cTnT的影响

发布时间：2018-07-03 21:12

本文选题：非ST段抬高型急性心肌梗死 + 波立维　；参考：《辽宁中医杂志》2017年05期

【摘要】：目的:探讨波立维联合通心络胶囊治疗非ST段抬高型急性心肌梗死的疗效及对肌酸激酶(CK)、同工酶(CK-MB)和肌钙蛋白T(c Tn T)的影响。方法:选取2014年1月—2016年1月我院收治的非ST段抬高型急性心肌梗死患者68例,按照随机分配的原则,将其平均分为两组,对照组与观察组,各34例。对照组采用波立维进行治疗,观察组采用波立维联合通心络胶囊进行治疗。对比两组临床治疗效果,以及治疗后CK、CK-MB、c Tn T的水平。结果:对照组的治疗总有效率为82.35%,观察组的治疗总有效率为94.12%,观察组治疗总有效率高于对照组,差异具有统计学意义(P0.05)。治疗后,两组CK、CK-MB、c Tn T水平较治疗前明显降低,观察组的CK、CK-MB、c Tn T水平明显低于对照组,差异具有统计学意义(P0.05)。结论:波立维联合通心络胶囊治疗非ST段抬高型急性心肌梗死的疗效确切,值得在临床上进一步推广应用。
[Abstract]:Objective: to investigate the effect of Polyvir combined with Tongxinluo capsule on creatine kinase (CK), isoenzyme (CK-MB) and troponin T (c TnT) in patients with non St segment elevation acute myocardial infarction (AMI). Methods: Sixty-eight patients with non-ST-segment elevation acute myocardial infarction admitted in our hospital from January 2014 to January 2016 were divided into two groups according to the principle of random distribution: the control group and the observation group, each with 34 cases. The control group was treated with Polydovir, and the observation group with Borivir combined with Tongxinluo capsule. The clinical effect and the level of CK-MBN T after treatment were compared between the two groups. Results: the total effective rate of treatment in the control group was 82.35 and that in the observation group was 94.12. The total effective rate in the observation group was higher than that in the control group (P0.05). After treatment, the level of CK-MBN / c TnT in the two groups was significantly lower than that before treatment, and the level of CK-MBN / c TnT in the observation group was significantly lower than that in the control group (P0.05). Conclusion: Borivir combined with Tongxinluo capsule in the treatment of non-St segment elevation acute myocardial infarction is effective and worthy of further clinical application.
【作者单位】：玉林市第一人民医院心血管内科;玉林市第一人民医院药学部;
【基金】：玉林市科学研究与技术开发计划项目(20161619)
【分类号】：R542.22

【参考文献】